TW200730172A - Cyclohexane derivatives - Google Patents
Cyclohexane derivativesInfo
- Publication number
- TW200730172A TW200730172A TW095144075A TW95144075A TW200730172A TW 200730172 A TW200730172 A TW 200730172A TW 095144075 A TW095144075 A TW 095144075A TW 95144075 A TW95144075 A TW 95144075A TW 200730172 A TW200730172 A TW 200730172A
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- optionally substituted
- cr3r4
- containing aromatic
- independently represents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005345252 | 2005-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200730172A true TW200730172A (en) | 2007-08-16 |
Family
ID=38092172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095144075A TW200730172A (en) | 2005-11-30 | 2006-11-29 | Cyclohexane derivatives |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2007063839A1 (zh) |
| TW (1) | TW200730172A (zh) |
| WO (1) | WO2007063839A1 (zh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8273900B2 (en) | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
| US20110201649A1 (en) * | 2008-09-19 | 2011-08-18 | Sumitomo Chemical Company, Limited | agricultural composition |
| EP2838530B1 (en) | 2012-04-20 | 2017-04-05 | UCB Biopharma SPRL | Methods for treating parkinson's disease |
| UY36390A (es) | 2014-11-05 | 2016-06-01 | Flexus Biosciences Inc | Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen |
| MX2017005462A (es) | 2014-11-05 | 2017-07-28 | Flexus Biosciences Inc | Agentes inmunorreguladores. |
| ES2907461T3 (es) * | 2015-01-20 | 2022-04-25 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos antihelmínticos, composiciones y procedimientos de uso de los mismos |
| CN110357813A (zh) * | 2018-04-09 | 2019-10-22 | 信达生物制药(苏州)有限公司 | 一种新型吲哚胺2,3-双加氧酶抑制剂及其制备方法和用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0928789B1 (en) * | 1996-07-31 | 2004-09-29 | Nikken Chemicals Company, Limited | 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and medicinal compositions containing the same |
| US6291499B1 (en) * | 1999-10-29 | 2001-09-18 | Merck & Co., Inc. | 2-cyclohexyl benzimidazole NMDA/NR2B antagonists |
| MXPA02010503A (es) * | 2000-06-06 | 2003-03-10 | Warner Lambert Co | Ciclohexilaminas biciclicas y su uso como antagonistas del receptor nmda. |
| EP1318974A2 (en) * | 2000-09-21 | 2003-06-18 | Pfizer Products Inc. | Resorcinol derivatives |
| HU227197B1 (en) * | 2000-10-24 | 2010-10-28 | Richter Gedeon Nyrt | Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them |
| MXPA02002749A (es) * | 2001-03-27 | 2002-10-28 | Warner Lambert Co | Derivados de ciclohexilamina como antagonistas del subtipo selectivo del n-metil-d-aspartato. |
| EP1451156A4 (en) * | 2001-11-27 | 2005-05-25 | Merck & Co Inc | 4-AMINOCHINOLINVERBINDUNGEN |
| KR100772297B1 (ko) * | 2002-11-22 | 2007-11-02 | 니뽄 다바코 산교 가부시키가이샤 | 융합 비시클릭 질소-함유 헤테로사이클 |
| MXPA05006487A (es) * | 2002-12-17 | 2005-08-26 | Pfizer | Compuestos cicloalquilenamida como antagonistas de receptor nr2b. |
| CN1835953A (zh) * | 2003-08-15 | 2006-09-20 | 默克专利 | 4-环烷基氨基吡唑并嘧啶nmda/nr2b拮抗剂 |
| EP1716100A2 (en) * | 2004-02-11 | 2006-11-02 | Pfizer, Inc. | Therapeutic amide derivatives |
-
2006
- 2006-11-28 JP JP2007547945A patent/JPWO2007063839A1/ja active Pending
- 2006-11-28 WO PCT/JP2006/323693 patent/WO2007063839A1/ja not_active Ceased
- 2006-11-29 TW TW095144075A patent/TW200730172A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007063839A1 (ja) | 2007-06-07 |
| JPWO2007063839A1 (ja) | 2009-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2520567A3 (en) | Nitrogen-containing heterocycle derivatives substituted with cyclic group | |
| MX2009005604A (es) | Inhibidores espiro cetona de acetil-coa carboxilasa. | |
| PH12012501331A1 (en) | Cyclic amide derivatives, and their production and use as antithrombotic agentss | |
| TW200716576A (en) | Heterocyclic derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 | |
| MY144588A (en) | Novel coumarin derivative having antitumor activity | |
| WO2009144555A8 (en) | Pyrazolospiroketone acetyl-coa carboxylase inhibitors | |
| TW200735877A (en) | Aminodihydrothiazine derivatives | |
| TW200642683A (en) | Heterocyclic compound | |
| SG155180A1 (en) | Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders | |
| DE602005005240D1 (de) | 4'-C-substituierte 2-Haloadenosinderivate | |
| WO2008021871A3 (en) | Triazolyl acyclic hepatitis c serine protease inhibitors | |
| WO2004000808A3 (en) | N-substituted piperidine derivatives as serotonin receptor agents | |
| MY142496A (en) | 2,4-diamino-pyrimidines as aurora inhibitors | |
| IN2012CN09242A (zh) | ||
| WO2008096820A1 (ja) | ビフェニル誘導体 | |
| WO2008149834A1 (ja) | ピリミドジアゼピノン誘導体 | |
| UA94065C2 (en) | Dihydropseudoerythromycin derivatives | |
| GB2442148A (en) | FK 228 derivates as HDAC inhibitors | |
| WO2008099874A1 (ja) | ピラジン誘導体を含有する医薬組成物およびピラジン誘導体を組み合わせて使用する方法 | |
| MX2009008756A (es) | Compuesto macrociclico. | |
| TW200606152A (en) | Piperidine compound and process for preparing the same | |
| WO2007121389A3 (en) | 4,4-disubstituted piperidine derivatives as nk-i and serotonin transporter inhibitors | |
| TW200730172A (en) | Cyclohexane derivatives | |
| MX2011009700A (es) | Derivado de amida. | |
| MX2009004314A (es) | Diaril, dipiridinil y arilpiridinilderivados y usos de los mismos. |